Sitagliptin vs Trastuzumab

## Sitagliptin vs Trastuzumab: Overview

This comparison examines the pharmacological differences between **Sitagliptin** and **Trastuzumab**.

## Mechanism of Action

**Sitagliptin**: DPP-4 inhibitor increasing incretin levels.

**Trastuzumab**: Anti-HER2 monoclonal antibody inhibiting receptor signaling.

## Pharmacokinetics

**Half-life**: Sitagliptin — 12.4 hours; Trastuzumab — 28 days.

## Chemical Properties

**Molecular Formula**: Sitagliptin — C16H15F6N5O; Trastuzumab — N/A.

**Molecular Weight**: Sitagliptin — 407.3140 g/mol; Trastuzumab — N/A.

**Type**: Sitagliptin — Small molecule; Trastuzumab — Antibody.